$10M Fund for Brain Degeneration Research Created by Lauder, Newhouse Foundations

$10M Fund for Brain Degeneration Research Created by Lauder, Newhouse Foundations
The Alzheimer's Drug Discovery Foundation (ADDF) and the Association for Frontotemporal Degeneration (AFTD) have announced a partnership to find a drug to cure or slow the progression of neurodegenerative diseases caused by the degeneration of neurons. The Lauder Foundation and the Samuel I. Newhouse Foundation will each invest $5 million for the development of effective therapies for frontotemporal degeneration (FTD). The initiative could also result in discoveries and improvements that may benefit and improve the quality of life of Alzheimer’s patients. The $10 million investment will create The Treat FTD Fund, which will hopefully accelerate clinical trials targeting this condition. The fund is a joint program from ADDF and AF
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *